Closing date: April 15
Glioblastoma is one of the most aggressive and lethal types of brain tumours. Radiotherapy remains a cornerstone of treatment; however, its effectiveness is often limited by the risk of damaging the surrounding healthy brain tissue.
Within the NuCapCure project, we are developing innovative compounds designed to exploit the tumour’s own biosynthetic machinery. These agents effectively turn cancer cells into intracellular “mini-chemistry laboratories,” forcing them to produce therapeutic drugs from within. The compounds are then further activated by proton therapy, an advanced and highly precise form of radiotherapy.
The NuCapCure agents will be validated and optimised using 2D and 3D glioblastoma cell culture models, after which the most promising candidates will be selected for in vivo evaluation. This approach has the potential to selectively target tumour cells while minimising damage to surrounding healthy brain tissue.
The project offers a highly multidisciplinary research environment, including physics, chemistry and cancer biology. The appointed post-doctoral researcher will play a central role in validating selected compounds in vivo, with a particular focus on assessing therapeutic responses in glioblastoma models.
More information about the NuCapCure project can be found here: https://nucapcure.eu
The University of Groningen and the University Medical Center Groningen (UMCG) provide an excellent working environment for high-quality biomedical research and scientific training. This post-doctoral position is based in the Department of Radiation Oncology at the UMCG and is embedded within the Department of Biomedical Sciences. The position is supervised by Dr. Lara Barazzuol and is part of an international project, NuCapCure, funded by the European Innovation Council (EIC).
Dr. Barazzuol’s research group investigates the side effects of cancer treatments and aims to widen the therapeutic window of proton therapy for brain and central nervous system (CNS) tumours. The team does so by integrating cutting-edge radiotherapy technologies with molecular targeting strategies. The goal is to translate these discoveries into improved clinical applications.
We are looking for an excellent and highly motivated post-doctoral candidate with strong laboratory skills, preferably with a background in brain tumour biology, neuroscience, in vivo modelling, or related fields.
Your salary will be € 5.669,- Post-doc (salary scale 10) per month. In addition, the UMCG will offer you 8% holiday pay, an 8.3% end-of-year bonus and a development budget. The duration of the project is 24 months. The initial contract will be for 1 year and after positive evaluation this will be extended for 1 additional year. Additionally, the UMCG offers an 8% holiday allowance, an 8.3% year-end bonus.The conditions of employment comply with the Collective Labour Agreement for Medical Centres (CAO-UMC).
For questions about the position
For more information about this position please contact:
Link
See website: https://umcgresearch.org/w/molecular-radiation-biology
umcgresearch.org/w/molecular-radiation-biology
Applying for a job
Your application should include:
Please use the the digital application form at the bottom of this page - only these will be processed. You can apply until 15 April 2026. Within half an hour after sending the digital application form you will receive an email- confirmation with further information.
We vinden het leuk als je contact met ons opneemt als je vragen hebt over het werken bij het UMCG.
